STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 81 filers reported holding STEMLINE THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 0.70 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $14,853,000 | -56.5% | 3,068,829 | -4.4% | 0.04% | -47.6% |
| Q4 2019 | $34,122,000 | -25.5% | 3,210,000 | -27.0% | 0.08% | -25.0% |
| Q3 2019 | $45,804,000 | -25.3% | 4,400,000 | +10.0% | 0.11% | -26.8% |
| Q2 2019 | $61,280,000 | +36.3% | 4,000,000 | +14.3% | 0.15% | +36.6% |
| Q1 2019 | $44,975,000 | +566.8% | 3,500,000 | +392.9% | 0.11% | +489.5% |
| Q4 2018 | $6,745,000 | -42.8% | 710,014 | 0.0% | 0.02% | -26.9% |
| Q3 2018 | $11,786,000 | -36.7% | 710,014 | -38.8% | 0.03% | -39.5% |
| Q2 2018 | $18,618,000 | -32.1% | 1,160,014 | -35.3% | 0.04% | -32.8% |
| Q1 2018 | $27,418,000 | +22.5% | 1,792,057 | +24.9% | 0.06% | +25.5% |
| Q4 2017 | $22,385,000 | +206.8% | 1,434,914 | +118.3% | 0.05% | +183.3% |
| Q3 2017 | $7,297,000 | – | 657,358 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management II, LLC | 315,980 | $3,381,000 | 1.62% |
| VHCP Management, LLC | 135,420 | $1,449,000 | 1.56% |
| Eventide Asset Management | 851,400 | $9,110,000 | 0.59% |
| CARL DOMINO INC | 26,000 | $278,000 | 0.30% |
| SABBY MANAGEMENT, LLC | 357,806 | $3,829,000 | 0.22% |
| Telemetry Investments, L.L.C. | 25,016 | $268,000 | 0.15% |
| J. Goldman & Co LP | 199,886 | $2,139,000 | 0.14% |
| BAILARD, INC. | 123,785 | $1,324,000 | 0.12% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 94,945 | $1,015,000 | 0.07% |
| Candriam S.C.A. | 244,000 | $2,611,000 | 0.06% |